3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
2
NET
1
Conditions
Neuroendocrine Tumors
14
Gastro-enteropancreatic neuroendocrine tumor
4
Carcinoid Tumor
3
Serotonin Syndrome
1
Neuroendocrine Tumors in Lung
1
Neoplastic Cells, Circulating
1
Gastrointestinal Neoplasms
1
Flushing
1
Diarrhea
1
Carcinoma, Hepatocellular
1
Adenoma, Islet Cell
1
Acromegaly
1
Interventions
telotristat ethyl
2
lanreotide
1
Random Allocation
1
Octreotide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Serotonin Syndrome
×
lanreotide
×
NET
×
Clear all
NCT00774930
2022-10-14
ELECT
Ipsen
Phase 3
Completed
115 enrolled
17 charts